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1. Introduction
Water is fundamental for human health and well-being as well as for stimulating diverse
socioeconomic activities. Paradoxically, these very activities have contributed to the alteration
and deterioration of water supply sources from a microbiological, physical and chemical
standpoint, causing sanitary risks for the population. For example: since the end of the 19th
century, the role of drinking water in exposing populations to pathogens, and improvements
in its quality in order to prevent diarrheic illnesses, has been widely analyzed, debated and
documented [1,2]; in the 20thcentury, epidemiological evidence was found of cutaneous lesions
[3]and various types of cancer related to hydroarsenicism [4], as well as dental and skeletal
fluorosis related to fluoride in drinking water [5].
In recent decades the problem of these possible public health risks from so-called emergent
contaminants (ECs) has been factored into the problem that includes a wide range of com‐
pounds whose environmental presence and impact have been proven with the advent of new
sensitive and reliable quantitative analytical tools [6]: ECs are bioactive substances synthesized
and used for the household, agriculture, livestock, industry, personal care products and
hygiene (PCPs), and human and veterinary medicine, including byproducts of production and
degradation [7].However, beyond the concentrations and environmental persistence of ECs,
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their relevance lies in the fact that they continue to be released into the environment through
various ways which confers ubiquity.
Chemical endocrine disruptors (EDs), which are xenobiotics (compounds exogenous or
foreign to living organisms) with potential to alter hormonal regulation and normal endocrine
system function, consequently affecting an intact organism, its progeny or subpopulations, are
among the wide range of ECs [8]. The evidence of adverse effects on aquatic organisms at
relevant environmental concentrations [9,10]is well documented as well as in vitro, in vivo and
epidemiological studies that associate human exposure to these compounds with: obesity,
metabolic syndrome, type II diabetes mellitus [11],estrogenic, androgenic and antiandrogenic
activity or combinations thereof [12], reproductive, nervous and immune systems effects, as
well as some cancers and developmental effects [13].
The presence of EDs in bodies of water is due mainly to the discharge of wastewater that
impacts the quality of surface water and groundwater with compounds that are not entirely
removed by conventional treatment processes [14,15], which is particularly relevant in areas
like the Mezquital Valley (state of Hidalgo, Mexico).The aquifer that supplies the population
is recharged with the residual waters used in agricultural irrigation. Another way is through
the indirect reuse of treated wastewater for potable water source augmentation. These
practices could explain why some pharmaceuticals (Phs) and personal care products (PCPs)
have been detected in waters treated for human consumption [16].
The concern regarding human exposure to EDs, in this case through water consumption, is
based on five points: 1) evidence of adverse effects on fish and aquatic ecosystems at relevant
environmental concentrations [9,10]; 2) documented clinical cases of cancers related to
hormones in industrialized nations [8], as well as prevalence of reproductive disorders in
adolescents and young men in Europe [17]; 3) in vivo studies that show endocrine disruption
through exposure to certain ambient chemicals; 4) various chemical compounds classified as
EDs or with potential to act as such, have been found in surface water and groundwater
[18]and, 5) evidence that suggests that conventional water treatment systems are inefficient in
removal of these types of contaminants [16].
The European Union, Germany, England, USA, Australia, Canada and Japan have all installed
multi-stage treatment systems that effectively reduce the concentration of EDs in drinking
water. The debate has begun over the need for research and regulation, analytical methods,
water sources and treated water monitoring, public health and environmental risks, water
treatment processes, transformation, transport and fate in the environment of EDs.
In Mexico there are few studies related to the occurrence of EDs in water, as well as few studies
that document the efficacy and efficiency of water treatment processes in the removal of ECs
and EDs. Considering that the Mezquital Valley is a prime example of an aquifer affected by
the reuse of wastewater, and that the occurrence of ECs has been documented in supply wells
in the area, the following objectives are proposed:
a. Analyze and synthesize information regarding the presence of EDs in supply sources and
treated waters for potable use, sanitary, environmental and regulatory relevance, treat‐
ment processes for removal from water.
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b. Analyze the problems related to ED exposure, specifically arsenic, bisphenol A, alkyl‐
phenols and their ethoxylates through the use and consumption of water in the Mezquital
Valley.
c. Analyze the technical feasibility of nanofiltration (NF) process to remove mineral and
organic compounds from groundwater in the area of the study.
d. Identify investigation needs regarding the occurrence concentration, persistence, trans‐
formation and destination, action mechanisms and risk assessment of EDs in water for
human consumption and treatment processes for potable use
2. Endocrine disruptors in drinking water: Public health relevance
By May 16, 2012, the Chemical Abstracts Service [19], had registered over 66.67 million organic
and inorganic substances. More than 100,000 man-made chemicals are available on the market
including approximately 1,500 new molecules released yearly [20,21] for manufacturing prod‐
ucts whose primary use is for human well-being and socioeconomic development. Since the
1990s, EDs have been one of the most controversial issues, attracting the attention of the scientif‐
ic community, international agencies and organizations, governments and the general public.
The U.S. Environmental Protection Agency defined an endocrine disruptor as “an exogenous
agent that interferes with the production, release, transport, metabolism, binding, action, or
elimination of natural hormones in the body responsible for the maintenance of homeostasis,
reproduction, development, and/ or behavior” [22]; the European Commission defines it as
“an exogenous substance or mixture that alters function(s) of the endocrine system and
consequently causes adverse health effects in an intact organism, or its progeny, or (sub)pop‐
ulations” [8]. From both definitions it is clear that EDs are compounds that alter hormonal
regulation or homeostasis that can cause undesirable adverse effects on health as a result of
exposure to a compound whose mechanism or action is endocrine disruption.
2.1. Origin and occurrence of EDs in drinking water
The nature and origin of EDs is diverse and includes groups of compounds such as: active
ingredients in medicines with collateral hormonal effect, pesticides and adjuvants for their
application, products to increase growth and weight gain in livestock, personal care and
hygiene products, flame retardants, chemicals for use in the plastic industry and other
frequently used industrial chemicals, natural and synthetic hormones, as well as products for
manufacturing consumer goods and degradation by products [20,22-26].
Their impact on public health and wildlife is due to their bioactivity and ubiquity in the
environment, as they are introduced unconsciously and permanently in the various environ‐
mental compartments. They can be introduced as pure substances or complex mixtures
through diverse ways, especially via the flow of treated or untreated wastewaters. These
compounds are not totally removed or inactivated by conventional water treatment systems
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or by natural processes of self-purification of the receiving bodies (water or ground), frequently
reaching groundwater [26-28].
For example, in the Mezquital Valley, the aquifer that supplies the population is recharged
mainly with wastewaters from Mexico City from agricultural irrigation; however, while the
contamination with EDs, Phs, and other organic compounds originate from these wastewaters,
they also originate from the disposal of PCPs and expired or unused medications by house‐
holds, municipal and hospital wastewater, leachates from landfills and local uncontrolled
garbage dumps (Figure 1, adapted from [29]), which is consistent with information published
by various authors for other aquifers [29-31].
In this case, as in scenarios of direct or indirect reuse of treated wastewater as water supply
source, the main concern is related to the pathogens as well as nitrates, Phs, PCPs and
disinfection byproducts with potential to disrupt the endocrine system and affect human and
environmental health [29].
In comparison to other chemical compounds, there is little information on the transformation
and fate of EDs especially regarding biotransformation, hydrolysis and photo transformation
of Phs and PCPs. Their low volatility suggests that their distribution in the environment will
occur mainly via aqueous transportation and dispersion through the food chain. The polar and
non-volatile nature of Phs impedes their release from water [31], without geographical or
climatic borders for these synthetic substances that have been found in areas that are consid‐
ered to have low pollution levels [32].
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Figure 1. Conceptual model of introduction and transportation of ECs and EDs in the Mezquital Valley.
ECs, EDs and PCPs have been frequently detected in effluents and surface waters that could
be present in drinking water. Ultra-trace concentrations (ng/L) of prescription and non-
prescription Phs and their metabolites have been reported in samples of drinking water across
International Perspectives on Water Quality Management and Pollutant Control28
the United States. These include caffeine, analgesics, anti-inflammatories (naproxen), anti-
convulsants (carbamazepine, phenytoin, primidone) and anxiolytics (meprobamate), xray
contrast medium (iopromide), lipid regulators (gemfibrozil), antibiotics or their metabolites,
nicotine metabolites, hypotensives (atenolol), synthetic musk, a polycyclic aromatic hydro‐
carbon compound, a plant sterol, plastic components, an insecticide, surfactants (bisphenol-
A, alkylphenols) and degradation products, a fixative used in perfumes and soaps, a flame
retardant and a pesticide [16,28,33-36].
In general throughout the water cycle there is a reduction in EDs through absorption, dilution,
and biodegradation [24], and yet there are still questions about their fate in the environment.
Laboratory studies have shown that bioactivity is reduced over a period of hours to days due
to degradation and sorption yet field studies indicate that estrogens are sufficiently mobile
and persistent to impact the surface and ground waters [37], while in the ground and sediments
where they can persist for long lengths of time (the half-life of clofibric acid, for example, is
estimated at 21 years), they reach levels in the g/kg range [23].
Given the ubiquitous nature of EDs, all humans are exposed through different tracks: inhala‐
tion, ingestion and dermal contact. Contributing to this is their low biodegradability, air and
water transportability, bio accumulation in the trophic chain and transgenerational exposure;
fetuses are especially vulnerable because pregnant women accumulate EDs in adipose tissue
[38].As with other environmental chemicals, their effects depend on the concentration and
nature of the chemical as well as its route, frequency and intensity with which exposure occurs
and in this case the phase of life at which the exposure occurs.
Due to the trace and ultra-trace concentrations in which EDs are found in drinking water,
people are commonly exposed in higher quantities through medications and other sources and
routes: diet, inhalation of airborne chemical substances and dermal absorption (topical
medication or personal care products), which suggests the contribution by drinking water to
the overall exposure and its relative importance in assessment of sanitary risks associated with
these types of contaminants [39].
Likewise from a risk management viewpoint, it is important to note that the variety and
chemical  structure of  EDs complicates their  identification and quantification in water as
well as the characterization of the sanitary risks associated with chronic exposure to low
or environmentally relevant doses In addition little is known about the occurrence, toxic‐
ity and potential endocrine activity of the products of degradation that may result from
the processes of bio and physiochemical transformation that alter the chemical structure
of EDs rather than eliminate them.
2.2. Human health effects
2.2.1. Endocrine system
Hormones are produced by the glands that comprise the endocrine system, which is the key
to communication within the human organism and control method between the nervous
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system and the various functions of the human body such as reproduction, immunity, energy
control, metabolism, conduct, growth and development. For example:
• The Thymus gland is the source of immunologic regulatory hormones [35].
• The Hypothalamus gland releases hormones such as oxytocin; it’s important in the control
of reproductive endocrine processes and stimulate pituitary activity [35,40,41].
• The Pituitary gland releases steroid hormones, such as corticosteroids, androgens, and
estrogens; growth hormone, oxytocin. Feedback control signals the endocrine organ (the
adrenal gland or gonads), to cease production or release of the endogenous steroid or to
stimulate the release of opposing hormones. This homeostatic control in response to
endogenous hormones is critical for maintaining proper hormone concentrations [35,40].
• The  Thyroid  gland  releases  thyroid  hormones  (calcitocin  and  thyroxine),  which  are
receptor nuclear of  steroids,  regulate metabolism, growth,  development,  behavior and
puberty [35,40,41].
• The Adrenal glands, release corticosteroid hormones, cathecolamines to regulate metabo‐
lism and behavior [40,41].
• The Pancreas produces insulin and glucagons to regulate blood sugar levels [40].
• The Ovaries and testicles produce sex steroids such as estrogen, progesterone, testosterone
(androgens and estrogens) [35,40].
This means that all the physiological systems sensitive to hormones are vulnerable to EDs, in‐
cluding the brain and hypothalamic-neuroendocrine systems, cardiovascular system, mamma‐
ry gland, adipose tissue, ovary and uterus in females, and testes and prostate in males [25,40].
2.2.2. Endocrine disruption mechanisms
Hormones circulate in the blood stream to modulate cellular and organ function through the
union with complex molecular receptors and mechanisms:
• They mimic natural hormones; if exposed to relatively high doses, they join receptors within
the cell and block or interfere with the ways through which hormones and receptors are
synthesized or controlled [42].
• Binding and activating estrogenic and androgenic receptors N40. There are a number of
estrogenic receptors in gonads, liver, brain, and sex organs; union without activation of the
receptor would act like anti-estrogenics or anti-androgenics [43-45].
• Binding without activation of the receptor would act like anti-estrogenics or anti-andro‐
genics [43-45].
• Modifying hormonal mechanisms [46], or of the number of hormonal receptors in the cell,
or of the production of natural hormones, for example in the thyroid, immune or nervous
systems [47].
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• Selectively inhibiting DNA transcription; for example, arsenic produces a disruption in the
transcription of DNA induced by the glucocorticoids mediated by receptors [47].
The mechanisms described in recent literature also include: a) the alteration of the transcription‐
al activity of nucleus receptors by modulating co-regulators through mediated degradation of
the proteasome as well as by inhibiting histone deacetilase activity and stimulating mitogenic
quinase protein activity; b) regulation of the methylation of DNA and c) modulation of lipid me‐
tabolism and adipogenesis, which possibly contribute to the current epidemic of obesity [47-50].
2.2.3. Health effects
EDs are structurally similar to many natural hormones; some have lipophilic properties [40],
act in extremely low concentrations and therefore can have effects on organisms with low dose
exposures [50,51]. As a result, environmental presence in trace and ultra-trace amounts,
particularly in water, may be insufficient to cause cellular death or act upon genetic material,
yet could result in a source of human exposure and carry sanitary risks for more susceptible
segments of the population.
The target hormones for EDs and the effects differ from one compound to another (as shown
in Table 1), as well as among species and intra species; for example, there are reports that the
median Bisphenol A (BPA) level in human blood and tissues, including in human fetal blood,
is higher than the level that causes adverse effects in mice [52].
The time of exposure to EDs in the organism in development is decisive in determining its
character and future potential and, even when critical exposure takes place during embryonic
development, the clinical manifestations may not be present until adulthood [8,43,45,46]. One
compound may act on different target hormones [40] and cause different alterations. A wide
and current review of the health risks is found in [22,53]. Some examples of compounds
intensively used in Mexico, and thier potential effects in in humans, are presented in Table 1,
as well as their normal application or use and the exposure source. It is worth mentioning that
the exposure is involuntary.
2.3. NF as an alternative to remove ECs from water
Between January 2001 and July 2004 the European Union conducted Project Poseidon [64];
among its objectives it proposed conducting integral studies to evaluate and improve the
removal of pharmaceuticals and personal care products from residential residual waters using
conventional and advanced treatments as well as with potable water. One of the conclusions
of the study is that reverse osmosis, nanofiltration and ultrafiltration-powdered activated
carbon are powerful processes for the removal of pharmaceuticals and personal care products,
among which are found ECs and EDs (suspicious and recognized).
In spite of the conclusions from the POSEIDON Project, the question about the efficacy of NF
membranes in removal of emergent contaminants persists. Many studies have been made of
this topic [65-73]. The spectrum of tests covers membranes with a molecular weight cut off
(MWCO) of 200, 400 and 600 Da, as well as organic compounds with different molecular
weights, sizes and physiochemical characteristics.
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Example Use Involuntary
exposure
source
Example of adverse effect in humans
Bisphenol A Plasticizers Plastic items,
packaging foods,
beverages, water
Estrogenic [52-55], thyroid hormone, progesterone[40], androgenic.
Female breast structural anomalies, premature thelarche, cancer;
pubertal timing variations, ovulatory disorders, sexual behavior,
prostate cancer [56,57]. Disrupted hypothalamic estrogenic
receptor distribution, altered nitric oxide syntheses signaling [57].
Affectation of human immune function [58], and disrupted
behavior in children associated with early life BPA exposure,
especially in girls [59].
Vinclozolin Fungicides Foods (fruit,
vegetables,
cereals), water
Estrogenic, anti-androgenic. Promotes transgenerational adult
onset disease such as male infertility, kidney and prostate diseases,
immune abnormalities and tumor development [60].
Alkylphenols Detergents,
emulsifiers,
agrochemicals
Household
items, water,
foods (fish)
Estrogenic [40], androgenic. Environmental and health issues
continue to cast uncertainty over the human risks of alkylphenols
and alkylphenols ethoxylates.
Phthalates Plasticizers Plastic items,
cosmetics,
personal
products care,
beverages, water
Estrogenic, androgenic, thyroid hormone [40]. Abnormalities such
as hypospadias, cryptorchidism, reduced anogenital distance.
Oligospermia, germ cell cancer [56]. Neurodevelopment and
metabolic endpoints are of concern, since studies of prenatal
exposure have found associations with phthalate exposure and
lowered IQs, and exposure has been implied as a risk factor for
obesity, insulin resistance and diabetes by others [47,50,55].
Diethylstilbestrol Contraception,
hormone replace
therapy
Pharmaceuticals.
They have been
detected in
water sources,
wastewater and
treated effluents
Estrogenic. Abnormalities such as hypospadias, cryptorchidism,
reduced anogenital distance. Female structural anomalies, breast
cancer, structural anomalies, premature thelarche. Prostate cancer
[56,61].
Ibuprofen,
diclofenac,
acetaminophen
Anti-inflammatory,
analgesics
Candidates may be identified on the basis of simple assumptions
regarding their use and activity: a) non estrogenic steroids may
react with environmental endocrine receptors or metabolize on
their way to the environment and thus form endocrine disruptors;
b) many high-volume drugs released to the environment have not
yet been tested for their endocrine properties, and some of these
are known to interact with the human endocrine system [62].
Bezafibrate,
clofibrate,
gemfibrozil,
fenofibrate
Lipidic regulator
Atenolol,
metoprolol,
propanolol
Β-blockers,
antihypertensives
Anabolic steroids;
trenbolone
acetate,
melengestrol
acetate
Fast growth of meat
producing animals
Animal food,
soil, wastewater
Androgenic. A placebo-controlled prospective study demonstrated
adverse and activating mood and behavioral effects of anabolic
steroids [63].
Table 1. Example of possible sources of exposure to EDs and target hormone system.
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NF efficiently removes dissolved solids, organic carbon, inorganic ions and organic micro
contaminants, both regulated and unregulated, and therefore its capacity is similar to that of
reverse osmosis (RO); however, due to higher pressure requirements the latter has higher
investment and operational costs. Furthermore the partial discrimination of calcium and
bicarbonates of the NF can be advantageous since drinking water distributed through
municipal networks should be saturated with calcium carbonate to avoid corrosion [74].
The mechanisms through which RO and NF reject organic compounds are mainly: a) ex‐
clusion by size  or  stericity;  b)  exclusion by repulsion of  charges  or  ionic  exclusion also
known as Donnan Effect and c) the physiochemical interaction of the solvent, the solute
and the membrane [75].
Size exclusion is associated with the molecular weight cut off of a membrane but this is relative
to a certain type of molecule, therefore other molecules with similar molecular weight yet
different physiochemical properties may not be rejected at the same rate. In the case of neutral
compounds, other geometric descriptors of the molecule are far more useful such as molecular
width [76]or hydrodynamic radius, especially for molecules whose radius approaches that of
the membrane pores [77].
Exclusion by charge repulsion is a phenomenon in highly typified NF membranes; tests
conducted with NF membranes and ultra-low pressure reverse osmosis to retain or reject 9
organic compounds (5 negative ionic charge and 4 neutral) showed that the electrically
negative charged compounds were rejected with efficiencies above 91% even with molecular
weights lower than the rated molecular weight cut off of the membranes, while the neutral
compounds were rejected at much lower rates at levels as low as 12% for 2-naphtol [78].
The interaction between solvent, solute and membrane can lead to misleading results if enough
time is not allotted for the process to normalize, since various organic contaminants tend to be
adsorbed on the membrane surfaces. As a result, initially they are retained, but once the
membrane surface is saturated, the true rejection of the compound can be observed [65,77-81].
NF membranes (MWCO of 200, 300 and 400 Da) and RO membranes (MWCO not reported)
have a 90% reject rate of ionic and non-ionic hydrophilic organic compounds such as naproxen,
diclofenac, ibuprophen, mecoprop, ketoprophen, gemfibrozil, and primidone and higher for
NF membranes with MWCO of 200 Da as well as the RO membranes. Even the NF membrane
with MWCO of 300 Da had reject rates of over 90% [68].
Tests conducted with a membrane with a MWCO of 300 Da (Filmtec NF200) to evaluate the
removal of hormones and antibiotics with microfiltration showed that in a matrix of drinking
water with a mixture of hormones and medications (i.e. hormones with sulfonamides or
tetracycline) it is possible to obtain rejects of nearly all of the substances with the exception of
testosterone whose reject rate was 95%. The pharmaceuticals tested were tetracyclines,
(chlorotetracycline, sulfachloropiridazine, sulfamerazine, sulfametoxazole, sulfametazole)
and hormones (estrogen, progesterone, testosterone and 17α-ethynilestradiol). There is also
evidence that the removal efficiency of hormones and sulfonamides was lower when de-
ionized water was used and a pure solute [72].
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As shown in the previous examples, the results obtained in the laboratory tests on efficiency
of NF membranes in the removal of ECs have been very favorable even though it has been
shown that compounds with a lower molecular weight, less branched and without ionic
charge, were only partially retained.
In pilot applications or full scale, the performance of NF in the control of organic micro
contaminants is less documented; even so, there are two pilot systems documented [67, 69]and
one municipal plant [73]. The main results of these two applications are described below.
A comparative study between ultra-low pressure reverse osmosis membranes (ULPRO) and
NF showed that both types of membrane can reach efficient levels of removal of organic
compounds such as pharmaceuticals, pesticides, flame retardants, plasticizers, and nitrogen,
similar to that of conventional reverse osmosis, producing water with equal quality as required
for indirect potable reuse of treated water. The operational conditions and results show that
both types of membrane are viable for reuse projects of treated residual water in which a high
quality permeate is required [67].
A NF pilot plant with a capacity of 56.4 L/min was fed with water from an advanced treatment
facility for residual water. After the biological treatment, the water was micro filtered and
disinfected. The pilot plant operated continuously for 1200 hours (50 days). Ten emergent
contaminants were found in the source water (3 plasticizers, [TCEP, TCPP, and TDCPP], acetyl
salicylic acid, naproxen, ketoprophen, diclofenac, gemfibrozil, primidone, and carbamaze‐
pine) and in all cases removal rates of 75-100% were observed, except during the first 24 hours
of operation when efficiencies were lower. However, as the test progressed, an increase in
removal of contaminants was observed to the degree that the organic compounds with ionic
charge and the neutral ones with greater molecular weight were rejected at a rate of 90%/.
A research study was held at a municipal drinking water facility located in the north of
Spain.  The plant  has 3 parallel  trains of  membrane processes,  two of  which are reverse
osmosis (486 m3/h each one) and one NF (360 m3/h).The facility is fed from groundwater
wells,  directly influenced by infiltration from Besós River.  During the study,  five meas‐
urement  campaigns,  aimed  at  12  pharmaceutical  compounds,  were  conducted.  The  re‐
sults  obtained indicate  that  NF was  capable  of  removing hydrochloratizide,  ketoprofen,
diclofenac,  sotalol,  sulfamethoxazole,  metopropolol,  propifenazone  and  carbamazepine
with efficiency levels above 90%.
Compounds with negative charges like gemfibrozil and mefenamic acid had a low removal
rate both in the NF (50% and 30% average), as well in RO (50% and 70% average). Meanwhile,
acetaminophen, which has a molecular weight cut off of 151.16 Da., had a removal rate of 44.8%
through NF and 73% through reverse osmosis. The authors conclude that the NF and reverse
osmosis membranes applied in full-scale are very efficient in removal of almost all pharma‐
ceutical residuals found in water.
Due to advantages NF has over RO, such as lower energy consumption and selective ion
discrimination, as well as the capability to remove almost all pharmaceutical residuals found
in water it was decided to test a NF process for water treatment at Mezquital Valley.
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3. Endocrine disruptors in groundwater sources of Mezquital Valley
3.1. Description of the study site
The Mezquital Valley is located in the central plateau of Mexico, 80 km. from Mexico City in
the South central part of the state of Hidalgo. In the municipalities located within the limits of
the aquifer of Mezquital Valley (Figure 2),there is an estimated population of 377,951 inhabi‐
tants, which represents 14.8% of the total population of the state [82].The principal economic
activity in the region is agriculture, which is distributed in two irrigation districts (03 Tula and
100 Alfajayucan). In the area there are also a petroleum refinery plant, a thermoelectric plant,
textile factories and a cement plant, considerable commercial activity, craft production, and
the tourist industry is based on spas and hiking in the mountains [83].
Figure 2. Location of the Mezquital Valley aquifer in Hidalgo State.
The climate is semi-arid, with a high incidence of sunlight and warm temperatures [83].
[83].Average annual precipitation is 450 mm, while evaporation is 2,100 mm; rain is limited to
the months of May through October [84].
Within the Mezquital Valley are the irrigation districts 03 Tula and 100 Alfajayucan, repre‐
senting one of the largest irrigation schemes of residual water in the world. It receives between
50 and 60 m3/s of water (80% residual and 20% pluvial) from Mexico City through the Gran
Canal del Desagüe, the Interceptor Poniente, and the Emisor Central (Figure 3)[85,86].
Around 75% of this water [87]is used without formal treatment for irrigation of approximately
85,000 hectares of saline soils that lead to high levels of irrigation (1.5 to 2.2 m) [86].Approximate‐
ly 10,000 hectares receive crude residual waters directly, 35,000 hectares receive mixed water
(80% residual and 20% from reservoirs and pluvial sources) and 25,000 hectares receive self-pu‐
rified residual water from the Requena, Endho, Rojo Gomez and Vicente Aguirre reservoirs [88].
The Emisor Central and Emisor Poniente join the Tula River to feed the Endho reservoir
(approximately 200 million m3) El Gran Canal empties into the Salado river and reaches the
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Tula river beyond the dam [88] (Figure 3). 81% of the main canals and 52% of the lateral canals
are not improved or coated, permitting the infiltration and artificial recharge of the aquifer.
The water outlets from the aquifer are through springs that lead to the Tula river, extraction
through wells, and the rest discharges toward the north and northwest, both superficially
(drained by the Salado river) as well as subterranean [85]. The estimated outflow from the
springs, which that spread out within the municipalities in the region, range from 100 to 600
L/s, and supply the population [86].
Figure 3. Sanitary sewers from Mexico City to the Mezquital Valley [85].
In the wastewaters, wells and springs in the Valle, sampling has shown traces of volatile and
non-volatile organic compounds, phenolic compounds, and some PAHs and PCB’s in con‐
centrations in the order of picograms/L. Likewise, the presence of benzylbuthylphthalate,
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diethylhexyl phthalate, nonylphenol, salicylic acid, carbamazepine, ibuprophen and naprox‐
en, indicate contamination from Phs and PCPs that include recognize and suspicious EDs
compounds [87,89,90].
3.2. Sampling sites
For the first monitoring campaign, 19 supply sources were selected (Figure 4) located within
the polygon that outlines the aquifer of the Mezquital Valley, and distributed throughout the
irrigation zone with untreated wastewater, mixed waters (wastewater and fluvial reservoir
water) and at a site to the north of the region to be used as a control site. The 11 sampling sites
of wastewater include the water that flows into the Valle via the Emisor Central, residual
waters from irrigation canals and one point in the Xotho canal that carries agricultural runoff
waters as a point of comparison (Figure 5).
 
2 “Tezoquipa“ Well 
3 “El Tablón” Well 
4 “Dendhó” Well 
5 “San Antonio” Well 
6 “El Refugio” Well 
7 “ Ajacuba” Well 
8 “Noria Tetepango” Well 
9 “Doxey” Well 
10 “Tlaxcoapan” Well 
11 “Teltipan” Well 
12 “El Puedhe” Well 
13 “Atengo” Well 
14 “Xochitlan” Well 
15 “Progreso” Spring” 
16 “Progreso” Well 
17 “Cerro Colorado” Spring 
18 “Fitzhi” Well 
19 “Chilcuautla” Well 
20 “Pedro Ma. Anaya” Well 
23 “El Llano” Well 
Figure 4. Supply sources.
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 W2 Emisor Central. Pipe/canal  
W3 El Salto. River 
W4 Salado. River 
W5 Tlamaco-Juandho. Canal 
W6 Salto-Tlamaco. Canal 
W7 Salto-Tlamaco 2. Canal 
W8 Requena 1. Canal 
W9 Dendho. Canal  
W10 Requena 2. Canal 
W12 Requena 3. Canal 
W13 Xotho. Canal 
Figure 5. Wastewater sample sites.
A second sampling was later conducted on eight supply sources to test for unregulated organic
compounds, phenolic compounds, estrogenic hormones, and a screening for pharmaceuticals,
personal care products and progestogenic hormones; a second more specific and selective
sampling was conducted of the supply sources in accordance with the following criteria:
• Concentrations of arsenic, fluorides, mercury or lead above maximum allowed limits as
established by the Mexican normative for potable waters.
• Abundance (qualitative) of unregulated organic compounds (volatile, semi-volatile and
persistent)
The sources selected were: 002 (Tezoquipa), 006 (El Refugio), 013 (Atengo), 014 (Xochitlan),
015 (Progreso spring), 017 (Cerro Colorado spring), 018 (Fitzhi) y 019 (Chilcuautla)
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3.3. Sampling
The procedure for gathering water samples to analyze compounds at the trace and ultra-trace
levels requires special care in order to not contaminate the samples by physical contact,
perspiration or exhalation. For this purpose a cap, powder free gloves and face masks were
used while handling, filling, closing, labeling and packaging the containers for storage and
transport.
Two people collected the samples; one was designated “dirty hands” and the other “clean
hands”. All operations requiring contact with the bottle and transferring the sample from the
collection vessel to the bottle were conducted by “clean hands,” and “dirty hands” was
responsible for all activities that did not involve direct contact with the sample [91].
3.4. Analytical methods
The samples were analyzed in laboratories accredited by the Entidad Mexicana de Acredita‐
miento, and the analytical methods utilized are based on the Mexican Standards or on
international methods or those applied in other countries and were implemented, standar‐
dized and or validated in the selected test labs for sample analysis. For the analysis of volatile
compounds, the samples were gathered in vials of 40 ml, and were kept at a temperature of
4°C during transport to the lab and until their analysis.
The samples were submitted for analysis through a methodology of USEPA Method 5030B
[92],using a gas Chromatograph Varian 3800 coupled to a mass spectrometer Saturn 2200
equipped with a capillary column Sample Concentrator Teckmar/Dohrmann Model 3100 and
auto sampler Varian Archon for 40 ml. vials.
The analysis of semi-volatile compounds was conducted with US-EPA Method 8270D [93].
Extractions were made in basic, neutral and acidic medium. The fractions obtained were
analyzed with gas chromatography-mass spectrometry in total ion monitoring mode. For the
analysis of noniphenols, method ASTM-D 7065-06 was applied. Dichloromethane was used
to extract the samples. The extracts were concentrated and dried with the use of anhydrous
sodium sulphate.
The detection of PPCPs was conducted by AXYS Laboratories in British Columbia Canada.
The samples were analyzed following the AXYS method MLA-075: Analytical Procedures for
the Analysis of Pharmaceutical and Personal Care Products in Solid, Aqueous and Tissue
Samples by LC-MS/MS[91]. This method is suitable for the determination of a suite of phar‐
maceutical and personal care compounds in aqueous, solid and tissue samples. The analysis
requires extraction at two different pH conditions: at pH 10 for analysis of fourteen analytes;
and at pH 2.0 for the analysis of the other analytes. Prior to extraction and/or clean-up, samples
are adjusted to the required pH and spiked with surrogates. A total of 119 analytes can be
identified and quantified. Analysis of the sample extract is performed on a high performance
liquid chromatography coupled to a triple quadrupole mass spectrometer. The LC/MS/MS is
run in MRM (Multiple Reaction Monitoring) mode and quantification is performed by
recording the peak areas of the applicable parent ion/daughter ion transitions. Some analytes
are analyzed in the ESI positive mode and some are analyzed in the ESI negative mode.
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3.5. Results
3.5.1. Fluoride and heavy metals: Suspected endocrine disrupters
The Mexican standard for drinking water quality [94], among other chemical parameters, limits
the concentration of heavy metals, fluoride, organochlorated pesticides, total trihalomethanes
and volatile organic compounds. In this framework, only four contaminants with potential to
cause endocrine disruption exceeded the established maximum contaminant level: Arsenic
(As), Fluorides (F), mercury (Hg) and lead (Pb) [95,96].
The greatest challenge came up in the wells in the south region of the Mezquital Valley (002
through 012 and 23), that are located in the entry zone of the residual waters. In the central
and northern zone of the valley high concentrations of fluorides were found (Table 2), which
is consistent with data reported in a previous study [85].
Parameter (Max allowable limit) Supply Source (concentration µg/L or mg/L)
Arsenic (25 µg/L) Wells: 003 (26), 004 (35.1) y006 (38.7)
Fluorides (1.5 mg/L) Wells: 004 (1.72), 006 (1.52), 009 (1.62), 012 (1.59);
Springs:015 (2.37), 017 (1.64);
Wells: 016 (3.32), 018 (3.04), 019 (2.98) 023 (3.77)
Mercury (1 µg/L) Wells:002 (2), 003(1.1), 006 (2.6), 007 (2.1) y 010 (2.6)
Lead (10 µg/L) Wells:002 (28), 003(30) y 004 (39)
Table 2. Supply sources and parameters of the Official Norm for Water for Human Consumption and Use that are not
met in the study zone.
Chronic exposure to As in drinking water has been strongly associated with increased risks of
multiple cancers, heart disease, diabetes mellitus II and reproductive and developmental
problems in humans [65].Recent studies suggest that increased human health risks [66],at
levels as low as 5-10 ppb, could be mediated, at least partially, through the capacity to alter
steroid receptors [97-99].There is evidence that high exposures to F- are associated with
decreased thyroid function [100,101], increased activity of the calcitonine and parathyroid,
secondary hyperparathyroidism, tolerance to glucose and possible effects over time on
reaching sexual maturity [96]. Lead (Pb) and mercury (Hg), can interfere with hormone
neurotransmitters and other growth factors, and in both cases any exposure can be considered
dangerous to the developing organism [57,102].
3.6. Unregulated organic compounds and estrogens
In the first monitoring campaign, 80 volatile and semi-volatile organic compounds (VSOCs)
were identified at a qualitative level. The south zone of the valley showed greater diversity of
organic contamination and in the north zone, where the irrigation water is mixed (wastewater
and fluvial reservoir water), the water supply sources also showed organic contamination
(Table 3 and Table 4), including naphthalene in well 019.
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Water sources in the central zone (wells007, 012, 013 and015) contained the least diversity of
organic compounds, nevertheless, no clear trend can be observed; therefore we assume that
human activities within the Valley represent an important contribution to the organic loading
(Table 3).
Supply source Number of organic
compound
Supply source Number of organic
compound
002 “Tezoquipa“ Well 22 003 “El Tablón” Well 17
004 “Dendhó” Well 17 005 “San Antonio” Well 26
006 “El Refugio” Well 26 007 “ Ajacuba” Well 18
008 “Noria Tetepango” Well 20 009 “Doxey” Well 17
010 “Tlaxcoapan” Well 17 011 “Teltipan” Well 22
012 “El Puedhe” Well 11 013 “Atengo” Well 17
014 “Xochitlan” Well 22 015 “Progreso” Spring” 8
016 “Progreso” 24 017 “Cerro Colorado” Spring 22
018 “Fitzhi” Well 29 019 “Chilcuautla” Well 31
020 “Pedro Ma. Anaya” Well 20 023 “El Llano” Well 17
Table 3. Number of volatile, semi-volatile and fixed organic compounds detected in water supply sources
Sampling site Number of organic
compound
Sampling site Number of organic
compound
AR “002 Emisor Central” Pipe/
canal
56 AR 003 “El Salto” River 37
AR 004 “Salado” River 42 AR 005 “Tlamaco Juandhó”
Canal
42
AR 006 “Salto-Tlamaco 1”
Canal
56 AR 007 “Salto-Tlamaco 2”
Canal
39
AR 008 “Principal Requena 1”
Canal
38 AR 009 “Principal Dendhó”
Canal
39
AR 010 “Principal Requena 2”
Canal
35 AR 012“Principal Requena 3”
Canal
32
AR 013 “Xotho” Canal 15
Table 4. Number of volatile, semi-volatile and fixed organic compounds detected in wastewater
In the second monitoring campaign conducted during the rainy season all eight supply sources
showed VSOCs (173 different ones). Qualitatively, the greatest contamination was observed
mainly in the central zone; the source with the highest contamination was 015 with 69 VSOCs
followed by 013 with 59 VSOCs; 017, 42; 006 and 014 with 41; 019, 38; 018, 36; and the source
least contaminated was Tezoquipa (002) where 32 VSOCs were found.
Endocrine Disruptors in Water Sources: Human Health Risks and EDs Removal from Water Through Nanofiltration
http://dx.doi.org/10.5772/54482
41
From both groups of compounds, the following are notorious for their presence in residual
waters and supply sources:
• Pesticides: 1,4-dichlorobencene, 1,2-dicloropropane, 3-chloro-2-methyl-1-propene, 1,1-
dichloro-1-nitroethane, 1,2,3,4-tetrahydronaphtalene.
• Flavorings and essences: 3-methyl-2-pentanone, 2-methylpentanoic acid, 2-pentanone, 5-
methyl-2-hexanone, 2,3-dichloro-2-methylbutane, 3-methyl-2-butanone, 2-propenilesther
acetic acid and methanotiol
• Cosmetic formulations, PCPs and industrial uses: ethylbencene, dietilphthalate, 1,2,4-
trimethylbenzene, methyl-isobutylcetone, eucaliptol, tetradecane, nonadecane.
Estrogenic hormones such as estrone, 17-β-estradiol, 17-β-estradiol acetate and 17-α-ethiny‐
lestradiol, were present in both residual waters and supply sources in ultra-trace amounts (ng/
L). The highest concentrations were found in the residual water from Mexico City and in the
Xotho canal (Table 5 and Table 6). The concentration of hormones in AR00 –Emisor Central
and AR003-El Salto and AR004-Salado rivers, AR013-Xotho canal and in 019-Chilcuautla well
is notable.
Supply source Concentration (ng/L) Supply source Concentration (ng/L)
002 “Tezoquipa“ Well 3.021 003 “El Tablón” Well 0.524
004 “Dendhó” Well 1.228 005 “San Antonio” Well 5.633
006 “El Refugio” Well 1.320 007 “ Ajacuba” Well 2.105
008 “Noria Tetepango” Well ND 009 “Doxey” Well ND
010 “Tlaxcoapan” Well 0.134 011 “Teltipan” Well 3.105
012 “El Puedhe” Well 3.080 013 “Atengo” Well ND
014 “Xochitlan” Well 0.158 015 “Progreso” Spring” ND
016 “Progreso” 1.176 017 “Cerro Colorado” Spring 5.660
018 “Fitzhi” Well 2.110 019 “Chilcuautla” Well 11.426
020 “Pedro Ma. Anaya” Well ND 023 “El Llano” Well 4.510
Table 5. Total estrogens in water supply sources (ND: no detected).
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Sampling site Concentration
(ng/L)
Sampling site Concentration
(ng/L)
W “002 Emisor Central” Pipe/
canal
86.032 W 003 “El Salto” River 68.725
W 004 “Salado” River ND W 005 “Tlamaco Juandhó” Canal ND
W 006 “Salto-Tlamaco 1” Canal 76.314 W 007 “Salto-Tlamaco 2” Canal 39.13
W 008 “Principal Requena 1”
Canal
11.74 W 009 “Principal Dendhó” Canal 114.599
W 010 “Principal Requena 2”
Canal
60.067 W 012“Principal Requena 3”
Canal
33.855
W 013 “Xotho” Canal 12.141
Table 6. Total estrogens in wastewater (ND: not detected).
In the second monitoring campaign six of the eight supply sources showed contamination
from Phs and PCPs (Table 8), in ultra-trace concentrations: erythromycin, sulfamethoxazole
(antibiotics), carbamazepine (antiepileptic), methylprednisolone (steroid anti-inflammatory
used in cases of allergy), DEET (PCP), caffeine and benzoilecgonine (metabolite of cocaine).
Chlofibric acid was found in 002-Tezoquipa (55.5 ng/L) and 003-El Tablón (36.67 ng/L), and
AR003-El Salto (41.32 ng/L). The same river also showed traces of gemfibrozil (63.2 ng/L).
Source Caffeine Benzoyl-
ecgonine
DEET Methyl-
prednisolone
Carba-
mazepine
Erithromycin-
H2O
Sulfa-
methoxasole
002 ND ND 0.948 12.9 ND ND 7.25
006 ND ND 1.64 ND ND 0.325 ND
013 24.3 4.93 2.01 ND 11.5 1.08 15.9
014 22.9 ND 1.01 ND ND 0.31 16.7
017 ND 0.318 0.923 5.2 5.24 1.35 10.4
019 ND ND 1.14 6.59 ND 1.05 22.8
Table 7. Pharmaceuticals and personal care products (concentration in ng/L; ND: not detected).
3.7. Bisphenol A, alkylphenols and alkylphenol-ethoxylates
As previously noted, bisphenol A and alkylphenols, including their ethoxylates, are relevant
from a public health standpoint for their potential to alter endocrine processes in humans and
aquatic and terrestrial organisms of various taxonomy. They are found in a variety of products
of frequent use and are used as an adjuvant in the application of pesticides, which explains
why, in the monitoring campaign that took place during the dry season, the highest concen‐
trations were found in residual waters of AR02-Emisor Central and in AR03-El Salto y AR04-
Salado rivers, as well as in the irrigation canals in the south zone. Furthermore, the
concentrations of these contaminants in the supply sources were not homogenous and there
was no obvious trend that suggested that wastewater from Mexico City was the only source
of contamination. This is why we concluded that there was an influence from the interior of
the Valley (Table 8. and Table 9).
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Supply source Concentration
(µg/L)
Supply source Concentration
(µg/L)
002 “Tezoquipa“ Well ND 003 “El Tablón” Well ND
004 “Dendhó” Well ND 005 “San Antonio” Well 2.29
006 “El Refugio” Well ND 007 “ Ajacuba” Well 4.23
008 “Noria Tetepango” Well 2.10 009 “Doxey” Well 6.07
010 “Tlaxcoapan” Well 3.7 011 “Teltipan” Well 2.51
012 “El Puedhe” Well 0.18 013 “Atengo” Well ND
014 “Xochitlan” Well 2.0 015 “Progreso” Spring” ND
016 “Progreso” ND 017 “Cerro Colorado” Spring ND
018 “Fitzhi” Well 0.18 019 “Chilcuautla” Well 1.12
020 “Pedro Ma. Anaya” Well ND 023 “El Llano” Well ND
Table 8. Total alkylphenols and etoxilates in water supply sources (ND: not detected).
Sampling site Concentration
(µg/L)
Sampling site Concentration
(µg/L)
W “002 Emisor Central” Pipe/canal 41.28 W 003 “El Salto” River 64.57
WW 004 “Salado” River 17.41 W 005 “Tlamaco Juandhó” Canal 40.73
W 006 “Salto-Tlamaco 1” Canal 19.03 W 007 “Salto-Tlamaco 2” Canal 24.29
W 008 “Principal Requena 1” Canal 43.82 W 009 “Principal Dendhó” Canal 94.87
W 010 “Principal Requena 2” Canal 23.84 W 012“Principal Requena 3” Canal 25.9
W013 “Xotho” Canal 1.52
Table 9. Total alkylphenols and etoxilates in wastewater.
3.8. Sanitary risks to the Mezquital Valley
Fifty-nine illnesses were identified as the primary causes of general mortality. Diabetes
mellitus type II is at the top of the list, and ischemic illnesses of the heart, cerebral vascular
ailments, diverse types of cancer (mainly breast, prostate, liver and leukemia) are among the
primary causes of death. These diseases are multi-causal and related in great part to diet and
life style as well as genetic and epigenetic factors; however environmental exposure to organic
and inorganic contaminants can also contribute to the risk of contracting these ailments, which
is why it is necessary to conduct studies that allows discovery or estimation of the contribution
of water to these diseases.
For both samplings, hazard of exposure to 173 ECs was qualitatively identified, of which 35
are of high priority for their carcinogenic potential or systemic toxicity and among these, for
their potential as EDs (acknowledged and suspicious [103-106]) and the frequency with which
they were found of note are:
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• Cosmetics, PCP and hygienic products formulations: ethylbenzene, octadecanoic acid
(stearic acid), octyl-dimethyl-paramino benzoate (Escalol 507) and DEET
• Pharmaceuticals: carbamazepine, methylprednisolone, erythromicine
• Pesticides: 1,4-diclorobenzene
• Industrial uses: 1,2-dichloropropane, benzene, chloroform, n-propylbenzene, tetrahydro‐
furane, tetrachloroethylene, 1,1,2-trichloroethane
• Plasticizers: di-isobuthylphthalate, dipropylphthalate
• Estrogens: estrone, 17-β-estradiol, 17-β-estradiol acetate and 17-α-ethinylestradiol
By using a methodological approach of health risk assessment and analyzing the results of a
survey completed by [107] from 1000 permanent residents in the Mezquital Valley, this study
estimated the exposure to contaminants identified as hazardous through the use and con‐
sumption of water. The ingested dose via this route was compared to values of toxicity
available on The Risk Assessment Information System data bases [108]. The hazard coefficient
was obtained for arsenic, fluoride, bisphenol A, nonilphenol, naphthalene, and esters of ftalic
acid or ftalates. The hazard coefficient or hazard index (HI) were estimated based on the
volume of water consumed, concentration of the analyte in the water, intensity, frequency and
magnitude of the oral exposure, body weight and the reference dose for critical effect in the
target organ. A HI of 1.0 or less indicates that the exposure poses no health risks.
Hazard Index greater  than 1.0  were  identified for  arsenic,  mercury and fluoride,  which
means  there  are  health  risks  associated  with  such  substances  in  drinking  water  (Table
10).  When such indexes are calculated for  municipalities,  greater  hazards are identified.
For example: Arsenic HI in Atitalaquia was 7.87 (± 5.08), in Progreso 2.29 (± 1.13) and in
Tlaxcoapan 5.23 (± 2.47); Fluorie HI in Atitalaquia was 3.31 (± 2.14), in Atotonilco de Tu‐
la 2.98 (± 1.65),  in Chilcuatla 4.68 (± 2.65),  in Ixmiquilpan 5.40 (± 2.81),  in Progreso 4.26
(± 2.33) and in Tlaxcoapan 3.03 (± 1.43).
Analyte Media HI Standard deviation Min HI Max HI
Arsenic 2.48E+00 4.07E+00 8.22E-03 2.41E+01
Mercury 3.26E-01 4.39E-01 0.00E+00 2.61E+00
Fluoride 3.95E+00 3.28E+00 2.74E-01 2.10E+01
Bisphenol A 7.18E-04 2.12E-03 0.00E+00 1.86E-02
4-Nonylphenol 2.81E-03 3.93E-03 0.00E+00 2.04E-02
Bis-2-(ethylhexyl)-phthalate 9.28E-03 3.51E-02 0.00E+00 3.07E-01
Diethylphthalate 5.78E-06 1.39E-05 0.00E+00 1.09E-04
Dibuthylphthalate 8.94E-04 3.04E-03 0.00E+00 2.68E-02
Table 10. Average Hazard Index from consumption of water with EDs (recognized and suspicious) within Mezquital Valley.
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Even though at present it is not possible to associate health risks with chronic ingestion of
organic EDs, there is uncertainty about exposure to small doses and the effects in the middle
and long terms, besides the concomitant exposure.
3.9. Water treatment test
Pilot scale testing was carried out to make sure NF was effective at removing certain minerals,
organic matter and ECs. Two supply sources within the valley were selected for this purpose.
The first phase of testing was conducted in the Cerro Colorado spring for 82 consecutive days.
This source supplies water to 4 municipalities within the Valley (Mixquiahuala, Progreso,
Tepacatepec and Tezontepec). Water characteristics are shown in Table 11. Due to these
mineral characteristics of the water (hardness and silica content) up to 72% water recovery can
be obtained.
Parameter Concentration Unit Parameter Concentration Unit
Cl― 148 mg/L Na 195.14 mg/L
F― 1.64 mg/L Hardness 237.1 mg CaCO3/L
HCO3 2― 271.53 mg CaCO3/L SDT 1,147 mg/L
SO4 169.96 mg/L pH 7.16
SiO2 63.1 mg/L
Table 11. Cerro Colorado Spring water quality.
Pilot scale NF tests were performed with a two stage skid; a 4:2 pressure vessel array with each
pressure vessel holding 3 standard elements (NE4040-90 CSM), respectively, was utilized.
Through brine recirculation, this design can simulate a two stage full-scale skid, employing
six (8” X 40”) elements per vessel.
In Figure 6 the pilot installation is shown: The whole treatment train includes sand filtra‐
tion, a 5 m3 filtered water storage tank, 10 µm cartridge filtration, antifouling agent addi‐
tion and NF.
The second phase of testing was conducted in the Tezoquipa well, located in Atitalaquia,
Hgo. It lasted 36 days. In the first monitoring campaign, we found that the concentration
of  dissolved  solids  in  this  well  was  among  the  lowest  in  the  Valley.  However,  heavy
metals  were  found in  the  water,  which is  why it  was  selected for  the  second phase  of
the water treatment test.
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Figure 6. Pilot unit including multimedia filtration and NF.
3.9.1. Rejection of mineral and organic compounds
To assess the performance of the NF pilot, six parameters were measured in feed water,
permeate and brine: Conductivity, SO42―, F―, Hardness, HCO3― and TOC. Figures 7, 8 and 9
show the rejection of those parameters monitored during water treatment tests.
Mineral content rejection, at the beginning of water treatment testing, was 80% (measuring
conductivity). This level of efficiency was about 10% below the rejection calculated with the
CSM4PRO design software (corresponding to membranes NE4040-90 of CSM). However, as
the test progressed, the salt rejection rose to 93%, which was very close to the calculations made
by CSM4PRO.
HCO3― removal was 92% on average (± 0.9981) while hardness was rejected at a higher rate of
97.46% on average, with a minimum of 95.12 and a maximum of 98.95%.
Sulphate removal was 98.78% on average, with a maximum of 99.57% and a minimum of
95.75%. These results are consistent with the characteristics of the membrane, since it is a
negatively charged hydrophobic membrane specialized in the removal of polyvalent anions.
Fluoride rejection oscillated between 80% and 96.77% (Figure 8). The variability in the results
could be explained by changes in feed water temperature. Filtered water coming from the
spring was stored in the 5m3 tank. The tank was exposed directly to sunlight, causing a rise in
water temperature. While samples and measurements were meant to be taken at 13:00 hours,
this was not always possible and there was no control over ambient temperatures.
Organic matter, measured as TOC, was rejected at a rate of 82% on average (Figure 9).
Nevertheless, its rejection rate varied from 41% to 100%. It is worth mentioning that in two of
the four measurements in which removal efficiency was less than 45%, the concentration of
TOC in the raw water was lower than 2 ppm; even so the variability is considerable.
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With respect to pharmaceuticals and personal care products, laboratory data indicates that the
membranes were capable of rejecting all of the sulfamethoxazole% (Table 12).
Figure 7. Major ions rejection observed in water tests.
Figure 8. Fluoride removal efficency observed in water treatment test.
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Erythromycin-H2O and cocaine were found in the brine but not in the feed water or permeate.
Given the low concentrations reported (fractions of nanograms), it is plausible that the raw
water contained these compounds at non-detectable levels and that they were rejected with
great efficiency, causing these substances to reach concentrations at a detectable and quanti‐
fiable level.
Figure 9. NF performance for organic matter removal.
Site Compound Concentration (ng/L)
Raw water Sulfamethoxazole
DEET
Metylprednizolone
7.25
0.948
12.9
Permeate DEET
Metylprednizolone
2.01
11
Brine Caffeine
Eritromicina-H2O
Sulfamethoxazole
Cocaine
DEET
14.5
0.654
18.8
0.172
0.848
Table 12. Pharmaceuticals and PCPs in water treatment test.
The NF membranes do not appear to be effective in the removal of DEET and are inefficient
in the removal of methylprednisolone. The molecular size of DEET is smaller than the
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Molecular Weight Cut-Off of the membrane. Also, DEET is a neutral molecule, so negatively
charged membranes won’t exert electrostatic repulsion. In the case of methylprednisolone, it
is of note that it was not found in the brine. This, according to the mass balance, is not possible.
In other words, if the concentration in the feed and the permeate streams are the same, the
same should be true for the brine.
Overall, groundwater quality within the Valley does not meet the Mexican Drinking Water
Quality Standard [94], from a total dissolved solids standpoint [94]. In some sources hardness,
sulphate, fluoride and heavy metals like lead, mercury and arsenic are present at concentra‐
tions exceeding the MCL. NF was able to reject all these substances at such a rate that the
permeate met the Mexican Drinking Water Quality Standard. From the mineral rejection
standpoint, NF seems to be an interesting alternative to treat the Mezquital Valley ground
water in order to produce drinking water.
4. Conclusions and research needs
In the semi-arid Mezquital Valley, reusing wastewater for agricultural purposes has benefitted
aquifer recharge, which has increased the availability of water destined for various human
activities, such as drinking water. Nevertheless, the presence of As, F, Hg and Pb and multiple
organic pollutants in 19 water sources that were sampled showed a wide variety of potential
health risks, including disruptions of the endocrine system.
The Hazard Quotients (HQ) estimated for the EDs (acknowledged and suspected) in the
mentioned area indicated risks associated (HC > 1.0) with As and F, while no risks were found
at the time of the study for organic EDs (phtalates, nonilphenols and bisphenol A). Neverthe‐
less, in water reuse scenarios such as this one, even with the limitations inherent to both point
monitoring and considering the lack of scientific knowledge.
It is necessary to emphasize the prevention of human exposure to EDs, considering that: a) the
effects of critical exposure during intrauterine, perinatal and puberty periods may not manifest
until adulthood; b) the population in the Mezquital Valley is exposed to a mixture of EDs that
could lead to the addition, synergy, potentiation or antagonism of effects, and c) it may be
assumed that the entire population is potentially exposed to these pollutants since, in quali‐
tative terms, all water sources presented at least one ED.
More monitoring campaigns focusing on EDs in a greater number of supply sources are neces‐
sary to quantify the EDs with greater precision and estimate exposure with higher accuracy.
Studies are required to integrate environmental aspects, life style and toxicological research
with epidemiology (cohort retrospective study or control cases) that allow associations to be
established between EDs exposure with ailments or specific health issues: i.e. diabetes mellitus
type II, the development of various types of cancer, reproductive function and processes and
neurodevelopment, which are currently of interest to various groups of researchers and the
governmental agencies responsible for regulation and policies in health, water and the
environment.
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On the other hand, the byproducts of the degradation and transformation of a compound can
also alter the hormonal system and, while a large number of researchers believe that physico‐
chemical characteristics of the molecules determine the molecules' behavior and environmen‐
tal distribution, a greater understanding of their action, transformation and environmental fate
are also required to assess and minimize the health risks associated with exposure to EDs in
concentrations relevant to drinking water.
Water delivered through public networks must be treated in order to comply with the Mexican
Standard for water quality. A NF process will remove mineral pollutants found in the
Mezquital Valley Nevertheless, from an ED standpoint, further tests are needed in order to
obtain enough evidence to determine if NF is capable of producing drinking water from these
sources, or another process is needed, either as a substitution (like RO) or a complement (like
activated carbon).
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